Changes in the Mean Corpuscular Volume after Capecitabine Treatment Are Associated with Clinical Response and Survival in Patients with Advanced Gastric Cancer

PURPOSE: Capecitabine is known to increase mean corpuscular volume (MCV). To define the incidence of capecitabine-induced macrocytosis and its association with chemotherapy outcomes, we investigated data of 89 patients with advanced gastric cancer (AGC) who were enrolled in a randomized chemotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Hyun Ae, Kim, Hyun-Jun, Maeng, Chi Hoon, Park, Se Hoon, Lee, Jeeyun, Park, Joon Oh, Park, Young Suk, Lim, Ho Yeong, Kang, Won Ki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4296847/
https://www.ncbi.nlm.nih.gov/pubmed/25143051
http://dx.doi.org/10.4143/crt.2013.172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4296847/
https://www.ncbi.nlm.nih.gov/pubmed/25143051
http://dx.doi.org/10.4143/crt.2013.172

Ejemplares similares